73:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
Consider inhaled corticosteroids (ICs) if the eosinophil :@0.533333:0.344749:0.928015:0.344749:0.928015:0.328967:0.533333:0.328967:0.011989:0.009601:0.008920:0.005564:0.002721:0.010054:0.009525:0.004248:0.006501:0.002721:0.008920:0.008920:0.010024:0.002721:0.009525:0.010054:0.006501:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.005564:0.006501:0.005277:0.003115:0.011989:0.007227:0.005277:0.006501:0.002721:0.004445:0.006501:0.004823:0.008920:0.009525:0.006501:0.009525:0.009601:0.005564:0.002721:0.008920:0.009601:0.010009:0.008920:0.002721:0.003024:0.004188
count is >300 cells/µL or >2% in the differential blood count.:@0.519045:0.360036:0.923843:0.360036:0.923843:0.344253:0.519045:0.344253:0.009480:0.009601:0.008890:0.008920:0.004823:0.003115:0.002721:0.005564:0.003115:0.008860:0.008074:0.008074:0.008074:0.003115:0.009480:0.009525:0.002721:0.002721:0.005564:0.006305:0.008406:0.006683:0.003115:0.009601:0.004248:0.003115:0.008860:0.008074:0.011415:0.003115:0.002721:0.008920:0.003115:0.004823:0.008920:0.009525:0.003115:0.010054:0.002721:0.004445:0.004445:0.009525:0.004248:0.009525:0.008920:0.004823:0.002721:0.010024:0.002721:0.003115:0.010009:0.002721:0.009601:0.009601:0.010054:0.003115:0.009480:0.009601:0.008890:0.008920:0.004823:0.004188
short-acting  beta-agonists (sABAs) last four  to  six :@0.533333:0.375322:0.927985:0.375322:0.927985:0.359539:0.533333:0.359539:0.007529:0.009223:0.009903:0.004551:0.005125:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.004188:0.006108:0.010311:0.009827:0.005125:0.010326:0.005020:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.010311:0.005579:0.007529:0.011188:0.008678:0.011188:0.005866:0.005579:0.010311:0.003024:0.010326:0.005866:0.005125:0.010311:0.004747:0.009903:0.009192:0.004551:0.004188:0.006108:0.005125:0.009903:0.004188:0.006108:0.005866:0.003024:0.007257:0.004188
hours and should be used on an as-needed basis or for :@0.519045:0.390608:0.928000:0.390608:0.928000:0.374825:0.519045:0.374825:0.009223:0.009903:0.009192:0.004551:0.005866:0.004475:0.010326:0.009223:0.010357:0.004490:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004490:0.010311:0.009827:0.004490:0.009192:0.005866:0.009827:0.010357:0.004490:0.009903:0.009223:0.004475:0.010326:0.009223:0.004475:0.010326:0.005866:0.005020:0.009223:0.009827:0.009827:0.010357:0.009827:0.010357:0.004475:0.010311:0.010326:0.005866:0.003024:0.005866:0.004490:0.009903:0.004551:0.004475:0.004747:0.009903:0.004551:0.004188
the patient in category A with few symptoms. Examples :@0.519045:0.405894:0.927955:0.405894:0.927955:0.390111:0.519045:0.390111:0.005125:0.009223:0.009827:0.004082:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004082:0.003024:0.009223:0.004082:0.009782:0.010326:0.005125:0.009827:0.010175:0.009903:0.004551:0.008104:0.004082:0.011188:0.004082:0.012564:0.003024:0.005125:0.009223:0.004082:0.004747:0.009827:0.012564:0.004082:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.004082:0.008104:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.005866:0.004188
of sABAs include albuterol or salbutamol and fenoterol. :@0.519045:0.421180:0.927320:0.421180:0.927320:0.405398:0.519045:0.405398:0.009903:0.004747:0.004188:0.007529:0.011188:0.008678:0.011188:0.005866:0.004188:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004188:0.010326:0.003024:0.010311:0.009192:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.009903:0.004551:0.004188:0.005866:0.010326:0.003024:0.010311:0.009192:0.005125:0.010326:0.014182:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.004747:0.009827:0.009223:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.004188
Long-acting  beta-agonists  (LABAs) with  a 12-hour :@0.533333:0.436466:0.928000:0.436466:0.928000:0.420684:0.533333:0.420684:0.006985:0.009903:0.009223:0.010175:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.004188:0.006093:0.010311:0.009827:0.005125:0.010326:0.005020:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.004188:0.006093:0.005579:0.006985:0.011188:0.008678:0.011188:0.005866:0.005579:0.010296:0.012564:0.003024:0.005125:0.009223:0.004188:0.006093:0.010326:0.010296:0.008376:0.008376:0.005020:0.009223:0.009903:0.009192:0.004551:0.004188
duration are formoterol and salmeterol. Those with a 24-:@0.519045:0.451753:0.923797:0.451753:0.923797:0.435970:0.519045:0.435970:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.003689:0.010326:0.004551:0.009827:0.003704:0.004747:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.003689:0.010326:0.009223:0.010357:0.003704:0.005866:0.010326:0.003024:0.014182:0.009827:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.003704:0.006441:0.009223:0.009903:0.005866:0.009827:0.003689:0.012564:0.003024:0.005125:0.009223:0.003704:0.010326:0.003704:0.008376:0.008376:0.005020
hour duration include indacaterol and olodaterol.:@0.519045:0.467039:0.884488:0.467039:0.884488:0.451256:0.519045:0.451256:0.009223:0.009903:0.009192:0.004551:0.004188:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004188:0.003024:0.009223:0.010357:0.010326:0.009782:0.010326:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.009903:0.003024:0.009903:0.010357:0.010326:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188
A long-acting antimuscarinic agent (LAMA) with a 12-:@0.533333:0.482325:0.923797:0.482325:0.923797:0.466542:0.533333:0.466542:0.011188:0.003780:0.003024:0.009903:0.009223:0.010175:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.003780:0.010326:0.009223:0.005125:0.003024:0.014182:0.009192:0.005866:0.009782:0.010326:0.004551:0.003024:0.009223:0.003024:0.009782:0.003795:0.010326:0.010175:0.009827:0.009223:0.005125:0.003780:0.005579:0.006985:0.011188:0.013894:0.011188:0.005579:0.003780:0.012564:0.003024:0.005125:0.009223:0.003795:0.010326:0.003795:0.008376:0.008376:0.005020
hour duration is aclidinium bromide. LAMAs with a 24-:@0.519045:0.497611:0.923812:0.497611:0.923812:0.481828:0.519045:0.481828:0.009223:0.009903:0.009192:0.004551:0.006078:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.006078:0.003024:0.005866:0.006093:0.010326:0.009782:0.003024:0.003024:0.010357:0.003024:0.009223:0.003024:0.009192:0.014182:0.006093:0.010311:0.004551:0.009903:0.014182:0.003024:0.010357:0.009827:0.004188:0.006078:0.006985:0.011188:0.013894:0.011188:0.005866:0.006078:0.012564:0.003024:0.005125:0.009223:0.006078:0.010326:0.006078:0.008376:0.008376:0.005020
hour duration are tiotropium, umeclidinium and glyco-:@0.519045:0.512897:0.923797:0.512897:0.923797:0.497115:0.519045:0.497115:0.009223:0.009903:0.009192:0.004551:0.005488:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.005503:0.010326:0.004551:0.009827:0.005503:0.005125:0.003024:0.009903:0.005125:0.004551:0.009903:0.010311:0.003024:0.009192:0.014182:0.004188:0.005488:0.009192:0.014182:0.009827:0.009782:0.003024:0.003024:0.010357:0.003024:0.009223:0.003024:0.009192:0.014182:0.005518:0.010326:0.009223:0.010357:0.005503:0.010175:0.003024:0.008104:0.009782:0.009903:0.005020
pyrronium bromide.:@0.519045:0.528183:0.662616:0.528183:0.662616:0.512401:0.519045:0.512401:0.010311:0.008104:0.004551:0.004551:0.009903:0.009223:0.003024:0.009192:0.014182:0.004188:0.010311:0.004551:0.009903:0.014182:0.003024:0.010357:0.009827:0.004188
Methylxanthine use is controversial due to its toxicity :@0.533333:0.543470:0.927985:0.543470:0.927985:0.527687:0.533333:0.527687:0.013894:0.009827:0.005125:0.009223:0.008104:0.003024:0.007257:0.010326:0.009223:0.005125:0.009223:0.003024:0.009223:0.009827:0.005851:0.009192:0.005866:0.009827:0.005866:0.003024:0.005866:0.005866:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.008361:0.009827:0.004551:0.005866:0.003024:0.010326:0.003024:0.005866:0.010357:0.009192:0.009827:0.005866:0.005125:0.009903:0.005851:0.003024:0.005125:0.005866:0.005866:0.005125:0.009903:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.004188
profile and modest bronchodilator ability.:@0.519045:0.558756:0.822273:0.558756:0.822273:0.542973:0.519045:0.542973:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.014182:0.009903:0.010357:0.009827:0.005866:0.005125:0.004188:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.010357:0.003024:0.003024:0.010326:0.005125:0.009903:0.004551:0.004188:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188
The combination of a LAMA and LABA in one inhaler :@0.533333:0.574042:0.927985:0.574042:0.927985:0.558259:0.533333:0.558259:0.006441:0.009223:0.009827:0.004929:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004929:0.009903:0.004747:0.004929:0.010326:0.004944:0.006985:0.011188:0.013894:0.011188:0.004929:0.010326:0.009223:0.010357:0.004929:0.006985:0.011188:0.008678:0.011188:0.004929:0.003024:0.009223:0.004929:0.009903:0.009223:0.009827:0.004929:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.004551:0.004188
shows greater efficacy than each agent on its own and :@0.519045:0.589328:0.928000:0.589328:0.928000:0.573546:0.519045:0.573546:0.005866:0.009223:0.009903:0.012564:0.005866:0.003840:0.010175:0.004551:0.009827:0.010326:0.005125:0.009827:0.004551:0.003840:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.003840:0.005125:0.009223:0.010326:0.009223:0.003840:0.009827:0.010326:0.009782:0.009223:0.003840:0.010326:0.010175:0.009827:0.009223:0.005125:0.003840:0.009903:0.009223:0.003840:0.003024:0.005125:0.005866:0.003840:0.009903:0.012564:0.009223:0.003840:0.010326:0.009223:0.010357:0.004188
is the reason for combination therapy.:@0.519045:0.604614:0.797629:0.604614:0.797629:0.588832:0.519045:0.588832:0.003024:0.005866:0.004188:0.005125:0.009223:0.009827:0.004188:0.004551:0.009827:0.010326:0.005866:0.009903:0.009223:0.004188:0.004747:0.009903:0.004551:0.004188:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
LAMA/LABA combinations are::@0.519045:0.627590:0.743412:0.627590:0.743412:0.611091:0.519045:0.611091:0.006652:0.011188:0.013607:0.011188:0.006955:0.006652:0.011188:0.008769:0.011188:0.004233:0.009676:0.009676:0.014212:0.009979:0.003629:0.009071:0.009979:0.004536:0.003629:0.009676:0.009071:0.006652:0.004233:0.009979:0.004838:0.009676:0.004233
•  12 hours: formoterol and glycopyrronium:@0.519045:0.642876:0.835275:0.642876:0.835275:0.627093:0.519045:0.627093:0.009162:0.004188:0.006804:0.008376:0.008376:0.004188:0.009223:0.009903:0.009192:0.004551:0.005866:0.004188:0.004188:0.004747:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.010175:0.003024:0.008104:0.009782:0.009903:0.010311:0.008104:0.004551:0.004551:0.009903:0.009223:0.003024:0.009192:0.014182
•  12-24 hours: indacaterol and glycopyrronium:@0.519045:0.658162:0.866798:0.658162:0.866798:0.642379:0.519045:0.642379:0.009162:0.004188:0.006804:0.008376:0.008376:0.005020:0.008376:0.008376:0.004188:0.009223:0.009903:0.009192:0.004551:0.005866:0.004188:0.004188:0.003024:0.009223:0.010357:0.010326:0.009782:0.010326:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.010175:0.003024:0.008104:0.009782:0.009903:0.010311:0.008104:0.004551:0.004551:0.009903:0.009223:0.003024:0.009192:0.014182
•  24 hours::@0.519045:0.673448:0.603062:0.673448:0.603062:0.657666:0.519045:0.657666:0.009162:0.004188:0.006804:0.008376:0.008376:0.004188:0.009223:0.009903:0.009192:0.004551:0.005866:0.004188
-  Vilanterol and umeclidinium:@0.540877:0.688734:0.760950:0.688734:0.760950:0.672952:0.540877:0.672952:0.005020:0.004188:0.005912:0.010614:0.003024:0.003024:0.010326:0.009223:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.009192:0.014182:0.009827:0.009782:0.003024:0.003024:0.010357:0.003024:0.009223:0.003024:0.009192:0.014182
-  Olodaterol and tiotropium:@0.540877:0.704021:0.747796:0.704021:0.747796:0.688238:0.540877:0.688238:0.005020:0.004188:0.005912:0.013138:0.003024:0.009903:0.010357:0.010326:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.005125:0.003024:0.009903:0.005125:0.004551:0.009903:0.010311:0.003024:0.009192:0.014182
iCs and lAbA combinations are::@0.519045:0.718406:0.755205:0.718406:0.755205:0.701908:0.519045:0.701908:0.004233:0.011793:0.007862:0.004233:0.009979:0.009071:0.009979:0.004233:0.006652:0.011188:0.008769:0.011188:0.004233:0.009676:0.009676:0.014212:0.009979:0.003629:0.009071:0.009979:0.004536:0.003629:0.009676:0.009071:0.006652:0.004233:0.009979:0.004838:0.009676:0.004233
•  Formoterol and beclomethasone:@0.520724:0.732792:0.782132:0.732792:0.782132:0.717009:0.520724:0.717009:0.009162:0.004188:0.005125:0.007333:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.009827:0.009782:0.003024:0.009903:0.014182:0.009827:0.005125:0.009223:0.010326:0.005866:0.009903:0.009223:0.009827
•  Formoterol and budesonide:@0.520724:0.747178:0.743669:0.747178:0.743669:0.731395:0.520724:0.731395:0.009162:0.004188:0.005125:0.007333:0.009903:0.004551:0.014182:0.009903:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.009192:0.010357:0.009827:0.005866:0.009903:0.009223:0.003024:0.010357:0.009827
table 1. Differential diagnosis of COPD:@0.077030:0.088780:0.354918:0.088780:0.354918:0.072281:0.077030:0.072281:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.010583:0.003629:0.004233:0.004233:0.009676:0.004838:0.009676:0.009071:0.004536:0.003629:0.009979:0.003629:0.004233:0.009979:0.003629:0.009979:0.009979:0.009071:0.009676:0.006652:0.003629:0.006652:0.004233:0.009676:0.004233:0.004233:0.011793:0.012700:0.008467:0.010583
Disease:@0.082070:0.107628:0.132601:0.107628:0.132601:0.092963:0.082070:0.092963:0.009407:0.003225:0.005913:0.008601:0.008870:0.005913:0.008601
suggestive features:@0.340357:0.107628:0.466954:0.107628:0.466954:0.092963:0.340357:0.092963:0.006988:0.008063:0.008870:0.008870:0.008601:0.005913:0.004032:0.003225:0.007526:0.008601:0.003763:0.003763:0.008601:0.008870:0.004032:0.008063:0.004301:0.008601:0.005913
COpD:@0.082070:0.123022:0.122629:0.123022:0.122629:0.108993:0.082070:0.108993:0.010926:0.011679:0.007956:0.009999
Mid-life onset, persistent symptoms, history of noxious particle exposure (smoking, :@0.340357:0.123022:0.867158:0.123022:0.867158:0.108993:0.340357:0.108993:0.012351:0.002688:0.009206:0.004462:0.002688:0.002688:0.004220:0.008735:0.003723:0.008803:0.008198:0.005214:0.008735:0.004556:0.003723:0.003723:0.009165:0.008735:0.004045:0.005214:0.002688:0.005214:0.004556:0.008735:0.008198:0.004556:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723:0.008198:0.008803:0.006451:0.002688:0.008803:0.008171:0.005214:0.003723:0.009165:0.009179:0.004045:0.004556:0.002688:0.008695:0.002688:0.008735:0.003723:0.008735:0.006451:0.009165:0.008803:0.005214:0.008171:0.004045:0.008735:0.003723:0.004959:0.005214:0.012606:0.008803:0.006746:0.002688:0.008198:0.009045:0.003723:0.003723
biomass fuel exposure – domestic or occupational):@0.340357:0.135851:0.672546:0.135851:0.672546:0.121822:0.340357:0.121822:0.009165:0.002688:0.008803:0.012606:0.009179:0.005214:0.005214:0.003723:0.004220:0.008171:0.008735:0.002688:0.003723:0.008735:0.006451:0.009165:0.008803:0.005214:0.008171:0.004045:0.008735:0.003723:0.006720:0.003723:0.009206:0.008803:0.012606:0.008735:0.005214:0.004556:0.002688:0.008695:0.003723:0.008803:0.004045:0.003723:0.008803:0.008695:0.008695:0.008171:0.009165:0.009179:0.004556:0.002688:0.008803:0.008198:0.009179:0.002688:0.004959
Asthma:@0.082070:0.151244:0.131768:0.151244:0.131768:0.137215:0.082070:0.137215:0.009945:0.005214:0.004556:0.008198:0.012606:0.009179
Early life onset, daily variability of symptoms, worse at night and early-morning, history of :@0.340357:0.151244:0.913268:0.151244:0.913268:0.137215:0.340357:0.137215:0.007203:0.009179:0.004045:0.002688:0.007203:0.003723:0.002688:0.002688:0.004220:0.008735:0.003723:0.008803:0.008198:0.005214:0.008735:0.004556:0.003723:0.003723:0.009206:0.009179:0.002688:0.002688:0.007203:0.003723:0.007445:0.009179:0.004045:0.002688:0.009179:0.009165:0.002688:0.002688:0.002688:0.004556:0.007203:0.003723:0.008803:0.004220:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.003723:0.009179:0.004556:0.003723:0.008198:0.002688:0.009045:0.008198:0.004556:0.003723:0.009179:0.008198:0.009206:0.003723:0.008735:0.009179:0.004045:0.002688:0.007203:0.004462:0.012606:0.008803:0.004045:0.008198:0.002688:0.008198:0.009045:0.003723:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723
allergy, eczema, rhinitis, childhood asthma, family history of asthma:@0.340357:0.164073:0.777210:0.164073:0.777210:0.150044:0.340357:0.150044:0.009179:0.002688:0.002688:0.008735:0.004045:0.009045:0.007203:0.003723:0.003723:0.008735:0.008695:0.005712:0.008735:0.012606:0.009179:0.003723:0.003723:0.004045:0.008198:0.002688:0.008198:0.002688:0.004556:0.002688:0.005214:0.003723:0.003723:0.008695:0.008198:0.002688:0.002688:0.009206:0.008198:0.008803:0.008803:0.009206:0.003723:0.009179:0.005214:0.004556:0.008198:0.012606:0.009179:0.003723:0.003723:0.004220:0.009179:0.012606:0.002688:0.002688:0.007203:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723:0.009179:0.005214:0.004556:0.008198:0.012606:0.009179
Cardiac failure:@0.082070:0.179467:0.179437:0.179467:0.179437:0.165438:0.082070:0.165438:0.010926:0.009179:0.004045:0.009206:0.002688:0.009179:0.008695:0.003723:0.004220:0.009179:0.002688:0.002688:0.008171:0.004045:0.008735
Chest x-ray shows enlarged heart, signs of pulmonary oedema, restrictive lung function :@0.340357:0.179467:0.908322:0.179467:0.908322:0.165438:0.340357:0.165438:0.010926:0.008198:0.008735:0.005214:0.004556:0.003723:0.006451:0.004462:0.004045:0.009179:0.007203:0.003723:0.005214:0.008198:0.008803:0.011168:0.005214:0.003723:0.008735:0.008198:0.002688:0.009179:0.004045:0.009045:0.008735:0.009206:0.003723:0.008198:0.008735:0.009179:0.004045:0.004556:0.003723:0.003723:0.005214:0.002688:0.009045:0.008198:0.005214:0.003723:0.008803:0.004220:0.003723:0.009165:0.008171:0.002688:0.012606:0.008803:0.008198:0.009179:0.004045:0.007203:0.003723:0.008803:0.008735:0.009206:0.008735:0.012606:0.009179:0.003723:0.003723:0.004045:0.008735:0.005214:0.004556:0.004045:0.002688:0.008695:0.004556:0.002688:0.007445:0.008735:0.003723:0.002688:0.008171:0.008198:0.009045:0.003723:0.004220:0.008171:0.008198:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723
rather than obstruction:@0.340357:0.192295:0.489585:0.192295:0.489585:0.178266:0.340357:0.178266:0.004045:0.009179:0.004556:0.008198:0.008735:0.004045:0.003723:0.004556:0.008198:0.009179:0.008198:0.003723:0.008803:0.009165:0.005214:0.004556:0.004045:0.008171:0.008695:0.004556:0.002688:0.008803:0.008198
Bronchiectasis:@0.082070:0.207689:0.174693:0.207689:0.174693:0.193660:0.082070:0.193660:0.007714:0.004045:0.008803:0.008198:0.008695:0.008198:0.002688:0.008735:0.008695:0.004556:0.009179:0.005214:0.002688:0.005214
Large volumes of often purulent sputa, history of lung infection, dilated bronchi and ring :@0.340357:0.207689:0.913563:0.207689:0.913563:0.193660:0.340357:0.193660:0.006209:0.009179:0.004045:0.009045:0.008735:0.003723:0.007445:0.008803:0.002688:0.008171:0.012606:0.008735:0.005214:0.003723:0.008803:0.004220:0.003723:0.008803:0.004220:0.004556:0.008735:0.008198:0.003723:0.009165:0.008171:0.004045:0.008171:0.002688:0.008735:0.008198:0.004556:0.003723:0.005214:0.009165:0.008171:0.004556:0.009179:0.003723:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723:0.002688:0.008171:0.008198:0.009045:0.003723:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.009206:0.002688:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.009165:0.004045:0.008803:0.008198:0.008695:0.008198:0.002688:0.003723:0.009179:0.008198:0.009206:0.003723:0.004045:0.002688:0.008198:0.009045:0.003723
shadows on HRCT* and chest x-ray:@0.340357:0.220517:0.565973:0.220517:0.565973:0.206488:0.340357:0.206488:0.005214:0.008198:0.009179:0.009206:0.008803:0.011168:0.005214:0.003723:0.008803:0.008198:0.003723:0.009179:0.008158:0.010926:0.005725:0.005712:0.003723:0.009179:0.008198:0.009206:0.003723:0.008695:0.008198:0.008735:0.005214:0.004556:0.003723:0.006451:0.004462:0.004045:0.009179:0.007203
Tuberculosis:@0.082070:0.235911:0.159385:0.235911:0.159385:0.221882:0.082070:0.221882:0.005725:0.008171:0.009165:0.008735:0.004045:0.008695:0.008171:0.002688:0.008803:0.005214:0.002688:0.005214
All ages, chest x-ray, infiltrates, microbiological evidence, high prevalence of TB:@0.340357:0.235911:0.857038:0.235911:0.857038:0.221882:0.340357:0.221882:0.009945:0.002688:0.002688:0.003723:0.009179:0.009045:0.008735:0.005214:0.003723:0.003723:0.008695:0.008198:0.008735:0.005214:0.004556:0.003723:0.006451:0.004462:0.004045:0.009179:0.007203:0.003723:0.003723:0.002688:0.008198:0.003272:0.003272:0.002688:0.004556:0.004045:0.009179:0.004556:0.008735:0.005214:0.003723:0.003723:0.012606:0.002688:0.008695:0.004045:0.008803:0.009165:0.002688:0.008803:0.002688:0.008803:0.009045:0.002688:0.008695:0.009179:0.002688:0.003723:0.008735:0.007445:0.002688:0.009206:0.008735:0.008198:0.008695:0.008735:0.003723:0.003723:0.008198:0.002688:0.009045:0.008198:0.003723:0.009165:0.004045:0.008735:0.007445:0.009179:0.002688:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.005725:0.007714
Obliterative bronchiolitis:@0.082070:0.251305:0.238381:0.251305:0.238381:0.237276:0.082070:0.237276:0.011679:0.009165:0.002688:0.002688:0.004556:0.008735:0.004045:0.009179:0.004556:0.002688:0.007445:0.008735:0.003723:0.009165:0.004045:0.008803:0.008198:0.008695:0.008198:0.002688:0.008803:0.002688:0.002688:0.004556:0.002688:0.005214
Younger age, non-smoker, may have rheumatoid arthritis or fume exposure, hypodense :@0.340357:0.251305:0.913456:0.251305:0.913456:0.237276:0.340357:0.237276:0.007956:0.008803:0.008171:0.008198:0.009045:0.008735:0.004045:0.003723:0.009179:0.009045:0.008735:0.003723:0.003723:0.008198:0.008803:0.008198:0.004462:0.005214:0.012606:0.008803:0.006746:0.008735:0.004045:0.003723:0.003723:0.012606:0.009179:0.007203:0.003723:0.008198:0.009179:0.007445:0.008735:0.003723:0.004045:0.008198:0.008735:0.008171:0.012606:0.009179:0.004556:0.008803:0.002688:0.009206:0.003723:0.009179:0.004045:0.004556:0.008198:0.004045:0.002688:0.004556:0.002688:0.005214:0.003723:0.008803:0.004045:0.003723:0.004220:0.008171:0.012606:0.008735:0.003723:0.008735:0.006451:0.009165:0.008803:0.005214:0.008171:0.004045:0.008735:0.003723:0.003723:0.008198:0.007203:0.009165:0.008803:0.009206:0.008735:0.008198:0.005214:0.008735:0.003723
areas on expiratory HRCT:@0.340357:0.264133:0.503737:0.264133:0.503737:0.250104:0.340357:0.250104:0.009179:0.004045:0.008735:0.009179:0.005214:0.003723:0.008803:0.008198:0.003723:0.008735:0.006451:0.009165:0.002688:0.004045:0.009179:0.004556:0.008803:0.004045:0.007203:0.003723:0.009179:0.008158:0.010926:0.005725
panbronchiolitis:@0.082070:0.279527:0.183831:0.279527:0.183831:0.265498:0.082070:0.265498:0.007956:0.009179:0.008198:0.009165:0.004045:0.008803:0.008198:0.008695:0.008198:0.002688:0.008803:0.002688:0.002688:0.004556:0.002688:0.005214
Mainly males of Asian ancestry, non-smokers.:@0.340357:0.279527:0.632242:0.279527:0.632242:0.265498:0.340357:0.265498:0.012351:0.009179:0.002688:0.008198:0.002688:0.007203:0.003723:0.012606:0.009179:0.002688:0.008735:0.005214:0.003723:0.008803:0.004220:0.003723:0.009945:0.005214:0.002688:0.009179:0.008198:0.003723:0.009179:0.008198:0.008695:0.008735:0.005214:0.004556:0.004045:0.007203:0.003723:0.003723:0.008198:0.008803:0.008198:0.004462:0.005214:0.012606:0.008803:0.006746:0.008735:0.004045:0.005214:0.003723
Rhinitis often present, HRCT shows centrilobular nodular opacities with hyperinflation.:@0.340357:0.292356:0.885892:0.292356:0.885892:0.278327:0.340357:0.278327:0.008158:0.008198:0.002688:0.008198:0.002688:0.004556:0.002688:0.005214:0.003723:0.008803:0.004220:0.004556:0.008735:0.008198:0.003723:0.009165:0.004045:0.008735:0.005214:0.008735:0.008198:0.004556:0.003723:0.003723:0.009179:0.008158:0.010926:0.005725:0.003723:0.005214:0.008198:0.008803:0.011168:0.005214:0.003723:0.008695:0.008735:0.008198:0.004556:0.004045:0.002688:0.002688:0.008803:0.009165:0.008171:0.002688:0.009179:0.004045:0.003723:0.008198:0.008803:0.009206:0.008171:0.002688:0.009179:0.004045:0.003723:0.008803:0.009165:0.009179:0.008695:0.002688:0.004556:0.002688:0.008735:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.002688:0.008198:0.003259:0.003259:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723
* – high-resolution computed tomography:@0.082070:0.306393:0.321253:0.306393:0.321253:0.294118:0.082070:0.294118:0.004998:0.003257:0.005880:0.003257:0.007173:0.002352:0.007914:0.007173:0.003904:0.003540:0.007644:0.004563:0.007702:0.002352:0.007150:0.003986:0.002352:0.007702:0.007173:0.003257:0.007608:0.007702:0.011030:0.008020:0.007150:0.003986:0.007644:0.008055:0.003257:0.003986:0.007702:0.011030:0.007702:0.007914:0.003540:0.008032:0.008020:0.007173:0.006303
with an efficacy of 45% and in reducing pneumococcal :@0.076190:0.344749:0.485115:0.344749:0.485115:0.328967:0.076190:0.328967:0.012564:0.003024:0.005125:0.009223:0.003583:0.010326:0.009223:0.003583:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.003583:0.009903:0.004747:0.003583:0.008376:0.008376:0.011717:0.003598:0.010326:0.009223:0.010357:0.003583:0.003024:0.009223:0.003583:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.003583:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009782:0.009903:0.009782:0.009782:0.010326:0.003024:0.004188
bacteraemia by 75%. pCV13 must be given at least a :@0.076190:0.359250:0.485130:0.359250:0.485130:0.343468:0.076190:0.343468:0.010311:0.010326:0.009782:0.005125:0.009827:0.004551:0.010326:0.009827:0.014182:0.003024:0.010326:0.005821:0.010311:0.008104:0.005821:0.008376:0.008376:0.011717:0.004188:0.005821:0.008950:0.012292:0.010614:0.008376:0.008376:0.005821:0.014182:0.009192:0.005866:0.005125:0.005821:0.010311:0.009827:0.005821:0.010175:0.003024:0.008376:0.009827:0.009223:0.005821:0.010326:0.005125:0.005821:0.003024:0.009827:0.010326:0.005866:0.005125:0.005821:0.010326:0.004188
year after the ppV23.  :@0.076190:0.373752:0.243658:0.373754:0.243658:0.357971:0.076190:0.357969:0.008104:0.009827:0.010326:0.004551:0.004188:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188:0.005125:0.009223:0.009827:0.004188:0.008950:0.008950:0.010614:0.008376:0.008376:0.004188:0.009701:0.601282
12:@0.229751:0.368455:0.239467:0.368455:0.239467:0.359301:0.229751:0.359301:0.004858:0.004858
Pharmacological treatment in stable COPD:@0.076190:0.405327:0.425944:0.405327:0.425944:0.386995:0.076190:0.386995:0.009407:0.010079:0.011087:0.005376:0.015791:0.011087:0.010751:0.010751:0.004032:0.010751:0.011087:0.004032:0.010751:0.011087:0.004032:0.004704:0.005040:0.005376:0.010751:0.011087:0.005040:0.015791:0.010751:0.010079:0.005040:0.004704:0.004032:0.010079:0.004704:0.007392:0.005040:0.011087:0.011087:0.004032:0.010751:0.004704:0.013103:0.014111:0.009407:0.011759
Long-acting  beta-agonist  agents  (LABAs)  and  long-:@0.076190:0.422001:0.480942:0.422001:0.480942:0.406218:0.076190:0.406218:0.006985:0.009903:0.009223:0.010175:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.004188:0.005549:0.010311:0.009827:0.005125:0.010326:0.005020:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.004188:0.005549:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188:0.005549:0.005579:0.006985:0.011188:0.008678:0.011188:0.005866:0.005579:0.004188:0.005549:0.010326:0.009223:0.010357:0.004188:0.005549:0.003024:0.009903:0.009223:0.010175:0.005020
acting antimuscarinic agents (LAMAs) are the drugs :@0.076190:0.436502:0.485145:0.436502:0.485145:0.420719:0.076190:0.420719:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.008436:0.010326:0.009223:0.005125:0.003024:0.014182:0.009192:0.005866:0.009782:0.010326:0.004551:0.003024:0.009223:0.003024:0.009782:0.008436:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.008436:0.005579:0.006985:0.011188:0.013894:0.011188:0.005866:0.005579:0.008436:0.010326:0.004551:0.009827:0.008436:0.005125:0.009223:0.009827:0.008436:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188
of choice in COpD. The newer agents have a 24-hour :@0.076190:0.451003:0.485130:0.451003:0.485130:0.435220:0.076190:0.435220:0.009903:0.004747:0.005745:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.005745:0.003024:0.009223:0.005760:0.012292:0.013138:0.008950:0.011249:0.004188:0.005745:0.006441:0.009223:0.009827:0.005745:0.009223:0.009827:0.012564:0.009827:0.004551:0.005745:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.005745:0.009223:0.010326:0.008376:0.009827:0.005760:0.010326:0.005760:0.008376:0.008376:0.005020:0.009223:0.009903:0.009192:0.004551:0.004188
duration  of  action  and are  given once  a day, which :@0.076190:0.465504:0.485130:0.465504:0.485130:0.449721:0.076190:0.449721:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.002464:0.009903:0.004747:0.004188:0.002464:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002464:0.010326:0.009223:0.010357:0.006667:0.010326:0.004551:0.009827:0.004188:0.002464:0.010175:0.003024:0.008376:0.009827:0.009223:0.006667:0.009903:0.009223:0.009782:0.009827:0.004188:0.002464:0.010326:0.006667:0.010357:0.010326:0.008104:0.004188:0.006667:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188
makes patient compliance easier. The Global Initiative :@0.076190:0.480005:0.485130:0.480005:0.485130:0.464222:0.076190:0.464222:0.014182:0.010326:0.007590:0.009827:0.005866:0.005216:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005201:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.010326:0.009223:0.009782:0.009827:0.005216:0.009827:0.010326:0.005866:0.003024:0.009827:0.004551:0.004188:0.005201:0.006441:0.009223:0.009827:0.005201:0.013184:0.003024:0.009903:0.010311:0.010326:0.003024:0.005216:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.008376:0.009827:0.004188
for Obstructive Lung Disease (GOLD) categorises COpD :@0.076190:0.494506:0.485145:0.494506:0.485145:0.478723:0.076190:0.478723:0.004747:0.009903:0.004551:0.004007:0.013138:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.008376:0.009827:0.004007:0.006985:0.009192:0.009223:0.010175:0.004007:0.011249:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004022:0.005579:0.013184:0.013138:0.006985:0.011249:0.005579:0.004022:0.009782:0.010326:0.005125:0.009827:0.010175:0.009903:0.004551:0.003024:0.005866:0.009827:0.005866:0.004007:0.012292:0.013138:0.008950:0.011249:0.004188
patients according to the level of FEV  and, secondly, :@0.076190:0.509007:0.485138:0.509014:0.485138:0.493231:0.076190:0.493224:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005700:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005700:0.005125:0.009903:0.005700:0.005125:0.009223:0.009827:0.005700:0.003024:0.009827:0.008376:0.009827:0.003024:0.005715:0.009903:0.004747:0.005700:0.007333:0.008104:0.010614:0.004846:0.005700:0.010326:0.009223:0.010357:0.004188:0.005700:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.003024:0.008104:0.004188:0.182675
1:@0.360324:0.508680:0.365182:0.508680:0.365182:0.499526:0.360324:0.499526:0.004858
according to the exacerbation frequency in conjunc-:@0.076183:0.523515:0.480950:0.523515:0.480950:0.507732:0.076183:0.507732:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005987:0.005125:0.009903:0.005987:0.005125:0.009223:0.009827:0.005987:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005987:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.009782:0.008104:0.005987:0.003024:0.009223:0.006002:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009797:0.005020
tion with the degree of effort-tolerance  impairment. :@0.076183:0.538016:0.485138:0.538016:0.485138:0.522233:0.076183:0.522233:0.005125:0.003024:0.009903:0.009223:0.008452:0.012564:0.003024:0.005125:0.009223:0.008452:0.005125:0.009223:0.009827:0.008452:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.008452:0.009903:0.004747:0.008452:0.009827:0.004747:0.004747:0.009903:0.004551:0.005125:0.005020:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.009223:0.009782:0.009827:0.004188:0.004248:0.003024:0.014182:0.010311:0.010326:0.003024:0.004551:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188
Treatment  choices are suggested according  to the :@0.076183:0.552517:0.485153:0.552517:0.485153:0.536734:0.076183:0.536734:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.005020:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.005866:0.009223:0.010326:0.004551:0.009827:0.009223:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.009827:0.010357:0.009223:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.004188:0.005020:0.005125:0.009903:0.009223:0.005125:0.009223:0.009827:0.004188
degree of impairment. The spirometry measurement of :@0.076183:0.567018:0.485108:0.567018:0.485108:0.551235:0.076183:0.551235:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.004974:0.009903:0.004747:0.004974:0.003024:0.014182:0.010311:0.010326:0.003024:0.004551:0.014182:0.009827:0.009223:0.005125:0.004188:0.004974:0.006441:0.009223:0.009827:0.004974:0.005866:0.010311:0.003024:0.004551:0.009903:0.014182:0.009827:0.005125:0.004551:0.008104:0.004974:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.014182:0.009827:0.009223:0.005125:0.004974:0.009903:0.004747:0.004188
FEV  is also used to quantify the degree of impairment, :@0.076183:0.581519:0.485139:0.581525:0.485139:0.565742:0.076183:0.565737:0.007333:0.008104:0.010614:0.004869:0.004914:0.003024:0.005866:0.004914:0.010326:0.003024:0.005866:0.009903:0.004914:0.009192:0.005866:0.009827:0.010357:0.004914:0.005125:0.009903:0.004899:0.010311:0.009192:0.010326:0.009223:0.005125:0.003024:0.004747:0.008104:0.004914:0.005125:0.009223:0.009827:0.004899:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.004899:0.009903:0.004747:0.004899:0.003024:0.014182:0.010311:0.010326:0.003024:0.004551:0.014182:0.009827:0.009223:0.005125:0.004188:0.087720
1:@0.102243:0.581191:0.107101:0.581191:0.107101:0.572037:0.102243:0.572037:0.004858
but it may not be widely available in general practice.:@0.076184:0.596026:0.475236:0.596026:0.475236:0.580243:0.076184:0.580243:0.010311:0.009192:0.005125:0.004188:0.003024:0.005125:0.004188:0.014182:0.010326:0.008104:0.004188:0.009223:0.009903:0.005125:0.004188:0.010311:0.009827:0.004188:0.012564:0.003024:0.010357:0.009827:0.003024:0.008104:0.004188:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.003024:0.009223:0.004188:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.004188:0.010311:0.004551:0.010326:0.009782:0.005125:0.003024:0.009782:0.009827:0.004188
The British Medical Research Council has a modified :@0.090471:0.610527:0.485124:0.610527:0.485124:0.594744:0.090471:0.594744:0.006441:0.009223:0.009827:0.005639:0.008678:0.004551:0.003024:0.005125:0.003024:0.005866:0.009223:0.005639:0.013894:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.005639:0.009177:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.005639:0.012292:0.009903:0.009192:0.009223:0.009782:0.003024:0.003024:0.005639:0.009223:0.010326:0.005866:0.005639:0.010326:0.005639:0.014182:0.009903:0.010357:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188
dyspnoea scale with a five-point scoring system from 0-4 :@0.076184:0.625028:0.485124:0.625028:0.485124:0.609245:0.076184:0.609245:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.003372:0.005866:0.009782:0.010326:0.003024:0.009827:0.003372:0.012564:0.003024:0.005125:0.009223:0.003372:0.010326:0.003372:0.003681:0.003681:0.008376:0.009827:0.005020:0.010311:0.009903:0.003024:0.009223:0.005125:0.003356:0.005866:0.009782:0.009903:0.004551:0.003024:0.009223:0.010175:0.003356:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.003372:0.004747:0.004551:0.009903:0.014182:0.003356:0.008376:0.005020:0.008376:0.004188
(mMRC), summarised as follows.:@0.076184:0.639529:0.310423:0.639529:0.310423:0.623747:0.076184:0.623747:0.005579:0.014182:0.013894:0.009177:0.012292:0.005579:0.004188:0.004188:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.010326:0.005866:0.004188:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.005866:0.004188
1:@0.310432:0.634235:0.315290:0.634235:0.315290:0.625081:0.310432:0.625081:0.004858
•  mMRC 0 – dyspnoea with strenuous exercise:@0.076190:0.654036:0.419513:0.654036:0.419513:0.638253:0.076190:0.638253:0.009162:0.004188:0.006804:0.014182:0.013894:0.009177:0.012292:0.004188:0.008376:0.004188:0.007560:0.004188:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.005866:0.005125:0.004551:0.009827:0.009223:0.009192:0.009903:0.009192:0.005866:0.004188:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827
•  mMRC 1 – dyspnoea hurrying up hills, inclines:@0.076190:0.668537:0.423943:0.668537:0.423943:0.652754:0.076190:0.652754:0.009162:0.004188:0.006804:0.014182:0.013894:0.009177:0.012292:0.004188:0.008376:0.004188:0.007560:0.004188:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.004188:0.009223:0.009192:0.004551:0.004551:0.008104:0.003024:0.009223:0.010175:0.004188:0.009192:0.010311:0.004188:0.009223:0.003024:0.003024:0.003024:0.005866:0.004188:0.004188:0.003024:0.009223:0.009782:0.003024:0.003024:0.009223:0.009827:0.005866
•  mMRC 2 – dyspnoea walking at own pace on level :@0.076190:0.683038:0.485130:0.683038:0.485130:0.667255:0.076190:0.667255:0.009162:0.004188:0.006804:0.014182:0.013894:0.009177:0.012292:0.005413:0.008376:0.005413:0.007560:0.005413:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.005413:0.012564:0.010326:0.003024:0.007590:0.003024:0.009223:0.010175:0.005413:0.010326:0.005125:0.005413:0.009903:0.012564:0.009223:0.005397:0.010311:0.010326:0.009782:0.009827:0.005413:0.009903:0.009223:0.005397:0.003024:0.009827:0.008376:0.009827:0.003024:0.004188
ground:@0.096344:0.697539:0.149744:0.697539:0.149744:0.681756:0.096344:0.681756:0.010175:0.004551:0.009903:0.009192:0.009223:0.010357
•  mMRC 3 – dyspnoea after a few minutes or 100 metres :@0.076190:0.712040:0.485191:0.712040:0.485191:0.696257:0.076190:0.696257:0.009162:0.004188:0.006804:0.014030:0.013743:0.009026:0.012141:0.003387:0.008225:0.003387:0.007408:0.003387:0.010205:0.007953:0.005715:0.010160:0.009071:0.009752:0.009676:0.010175:0.003387:0.010175:0.004596:0.004974:0.009676:0.004400:0.003387:0.010175:0.003387:0.004596:0.009676:0.012413:0.003387:0.014030:0.002873:0.009071:0.009041:0.004974:0.009676:0.005715:0.003387:0.009752:0.004400:0.003387:0.008225:0.008225:0.008225:0.003387:0.014030:0.009676:0.004974:0.004400:0.009676:0.005866:0.004188
on level ground:@0.096344:0.726541:0.211324:0.726541:0.211324:0.710759:0.096344:0.710759:0.009903:0.009223:0.004188:0.003024:0.009827:0.008376:0.009827:0.003024:0.004188:0.010175:0.004551:0.009903:0.009192:0.009223:0.010357
•  mMRC 4 – dyspnoea on dressing, washing – unable :@0.076190:0.741042:0.485130:0.741042:0.485130:0.725260:0.076190:0.725260:0.009162:0.004188:0.006804:0.014182:0.013894:0.009177:0.012292:0.005382:0.008376:0.005397:0.007560:0.005397:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.005397:0.009903:0.009223:0.005382:0.010357:0.004551:0.009827:0.005866:0.005866:0.003024:0.009223:0.010175:0.004188:0.005382:0.012564:0.010326:0.005866:0.009223:0.003024:0.009223:0.010175:0.005397:0.007560:0.005397:0.009192:0.009223:0.010326:0.010311:0.003024:0.009827:0.004188
to leave the house:@0.096344:0.755543:0.233504:0.755543:0.233504:0.739761:0.096344:0.739761:0.005125:0.009903:0.004188:0.003024:0.009827:0.010326:0.008376:0.009827:0.004188:0.005125:0.009223:0.009827:0.004188:0.009223:0.009903:0.009192:0.005866:0.009827
The exacerbation frequencies :@0.090478:0.770044:0.339791:0.770044:0.339791:0.754262:0.090478:0.754262:0.006441:0.009223:0.009827:0.016994:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.016994:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009207:0.009782:0.003024:0.009827:0.005866:0.004188
used are::@0.076190:0.784546:0.144513:0.784546:0.144513:0.768763:0.076190:0.768763:0.009192:0.005866:0.009827:0.010357:0.004188:0.010326:0.004551:0.009827:0.004188
•  One or less episode in the previ:@0.076190:0.799047:0.330568:0.799047:0.330568:0.783264:0.076190:0.783264:0.009162:0.004188:0.006804:0.013138:0.009223:0.009827:0.005231:0.009903:0.004551:0.005216:0.003024:0.009827:0.005866:0.005866:0.005231:0.009827:0.010311:0.003024:0.005866:0.009903:0.010357:0.009827:0.005231:0.003024:0.009223:0.005231:0.005125:0.009223:0.009827:0.005231:0.010311:0.004551:0.009827:0.008376:0.003024
-:@0.330568:0.799047:0.335588:0.799047:0.335588:0.783264:0.330568:0.783264:0.005020
ous year and not requiring hospi-:@0.096344:0.813548:0.335603:0.813548:0.335603:0.797765:0.096344:0.797765:0.009903:0.009192:0.005866:0.004022:0.008104:0.009827:0.010326:0.004551:0.004022:0.010326:0.009223:0.010357:0.004022:0.009223:0.009903:0.005125:0.004022:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.003024:0.009223:0.010175:0.004022:0.009223:0.009903:0.005866:0.010311:0.003024:0.005020
tal admission – describes classes :@0.096344:0.828049:0.339776:0.828049:0.339776:0.812266:0.096344:0.812266:0.005125:0.010326:0.003024:0.005367:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005367:0.007560:0.005367:0.010357:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.005866:0.005367:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.004188
A and B.:@0.096344:0.842550:0.158680:0.842550:0.158680:0.826767:0.096344:0.826767:0.011188:0.004188:0.010326:0.009223:0.010357:0.004188:0.008678:0.004188
•  Two  or  more  exacerbations  or :@0.076190:0.857051:0.339776:0.857051:0.339776:0.841268:0.076190:0.841268:0.009162:0.004188:0.006804:0.006441:0.012564:0.009903:0.004188:0.005216:0.009903:0.004551:0.004188:0.005216:0.014182:0.009903:0.004551:0.009827:0.004188:0.005216:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005216:0.009903:0.004551:0.004188
at least one hospital admission – :@0.096344:0.871552:0.339791:0.871552:0.339791:0.855769:0.096344:0.855769:0.010326:0.005125:0.004914:0.003024:0.009827:0.010326:0.005866:0.005125:0.004914:0.009903:0.009223:0.009827:0.004899:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004914:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009918:0.009223:0.004899:0.007560:0.004188
describes classes C and D.:@0.096344:0.886053:0.290699:0.886053:0.290699:0.870270:0.096344:0.870270:0.010357:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.005866:0.004188:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.004188:0.012292:0.004188:0.010326:0.009223:0.010357:0.004188:0.011249:0.004188
This is summarised into  ABCD :@0.090478:0.900554:0.339791:0.900554:0.339791:0.884772:0.090478:0.884772:0.006441:0.009223:0.003024:0.005866:0.013411:0.003024:0.005866:0.013411:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.013411:0.003024:0.009223:0.005125:0.009903:0.004188:0.009207:0.011188:0.008678:0.012292:0.011249:0.004188
compartments  in conjunction  with :@0.076190:0.915055:0.339791:0.915055:0.339791:0.899273:0.076190:0.899273:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.005125:0.014182:0.009827:0.009223:0.005125:0.005866:0.004188:0.002933:0.003024:0.009223:0.007136:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002933:0.012564:0.003024:0.005125:0.009223:0.004188
a mMRC score on the X-axis and an :@0.076190:0.930203:0.339791:0.930203:0.339791:0.914420:0.076190:0.914420:0.010326:0.003734:0.014182:0.013894:0.009177:0.012292:0.003734:0.005866:0.009782:0.009903:0.004551:0.009827:0.003734:0.009903:0.009223:0.003734:0.005125:0.009223:0.009827:0.003734:0.009207:0.005020:0.010326:0.007257:0.003024:0.005866:0.003750:0.010326:0.009223:0.010357:0.003734:0.010326:0.009223:0.004188
exacerbation rate on the Y-axis.:@0.076190:0.945351:0.310188:0.945351:0.310188:0.929568:0.076190:0.929568:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004551:0.010326:0.005125:0.009827:0.004188:0.009903:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.008950:0.005020:0.010326:0.007257:0.003024:0.005866:0.004188
1:@0.310159:0.940064:0.315017:0.940064:0.315017:0.930910:0.310159:0.930910:0.004858
>2 exacerbations:@0.382967:0.800587:0.495923:0.800587:0.495923:0.786558:0.382967:0.786558:0.008144:0.007445:0.003723:0.008735:0.006451:0.009179:0.008695:0.008735:0.004045:0.009165:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214
>1 hospital admission:@0.382967:0.813415:0.520289:0.813415:0.520289:0.799386:0.382967:0.799386:0.008144:0.007445:0.003723:0.008198:0.008803:0.005214:0.009165:0.002688:0.004556:0.009179:0.002688:0.003723:0.009179:0.009206:0.012606:0.002688:0.005214:0.005214:0.002688:0.008803:0.008198
0-1 exacerbation :@0.382967:0.841685:0.498195:0.841685:0.498195:0.827656:0.382967:0.827656:0.007445:0.004462:0.007445:0.003723:0.008735:0.006451:0.009179:0.008695:0.008735:0.004045:0.009165:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723
(no admission):@0.382967:0.854513:0.477404:0.854513:0.477404:0.840484:0.382967:0.840484:0.004959:0.008198:0.008803:0.003723:0.009179:0.009206:0.012606:0.002688:0.005214:0.005214:0.002688:0.008803:0.008198:0.004959
C:@0.585311:0.820715:0.603218:0.820715:0.603218:0.786387:0.585311:0.786387:0.017908
 LAMA:@0.603225:0.815861:0.645397:0.815861:0.645397:0.801832:0.603225:0.801832:0.003723:0.006209:0.009945:0.012351:0.009945
D:@0.756660:0.814301:0.777322:0.814301:0.777322:0.779972:0.756660:0.779972:0.020663
 LAMA: LAMA+LABA: :@0.777330:0.809447:0.914799:0.809447:0.914799:0.795418:0.777330:0.795418:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.003723:0.006209:0.009945:0.012351:0.009945:0.008144:0.006209:0.009945:0.007714:0.009945:0.003723:0.003723
LABA+ICs:@0.756661:0.822275:0.819274:0.822275:0.819274:0.808246:0.756661:0.808246:0.006209:0.009945:0.007714:0.009945:0.008144:0.003037:0.010926:0.006693
1:@0.819268:0.817565:0.823587:0.817565:0.823587:0.809428:0.819268:0.809428:0.004318
A:@0.585311:0.860483:0.604764:0.860483:0.604764:0.826154:0.585311:0.826154:0.019453
 Any bronchodilator:@0.604751:0.855629:0.734613:0.855629:0.734613:0.841600:0.604751:0.841600:0.003723:0.009945:0.008198:0.007203:0.003723:0.009165:0.004045:0.008803:0.008198:0.008695:0.008198:0.008803:0.009206:0.002688:0.002688:0.009179:0.004556:0.008803:0.004045
B:@0.756660:0.860483:0.774937:0.860483:0.774937:0.826154:0.756660:0.826154:0.018277
 LAMA / LABA:@0.774935:0.855629:0.864238:0.855629:0.864238:0.841600:0.774935:0.841600:0.003723:0.006209:0.009945:0.012351:0.009945:0.003723:0.005873:0.003723:0.006209:0.009945:0.007714:0.009945
mMRC 0-1:@0.622696:0.894319:0.689811:0.894319:0.689811:0.880290:0.622696:0.880290:0.012606:0.012351:0.008158:0.010926:0.003723:0.007445:0.004462:0.007445
mMRC >2:@0.796031:0.895011:0.859383:0.895011:0.859383:0.880982:0.796031:0.880982:0.012606:0.012351:0.008158:0.010926:0.003723:0.008144:0.007445
figure 2. suggested therapy guided by the AbCD categorisation of patients, :@0.380873:0.932323:0.932960:0.932323:0.932960:0.915824:0.380873:0.915824:0.007257:0.003629:0.009979:0.009071:0.004838:0.009676:0.003795:0.008467:0.004233:0.003810:0.007862:0.009071:0.009979:0.009979:0.009676:0.006652:0.004536:0.009676:0.009979:0.003810:0.004536:0.009071:0.009676:0.004838:0.009979:0.009979:0.008769:0.003810:0.009979:0.009071:0.003629:0.009979:0.009676:0.009979:0.003810:0.009979:0.008769:0.003810:0.004536:0.009071:0.009676:0.003810:0.011188:0.008769:0.011793:0.010583:0.003795:0.009676:0.009979:0.004536:0.009676:0.009979:0.009676:0.004838:0.003629:0.006652:0.009979:0.004536:0.003629:0.009676:0.009071:0.003795:0.009676:0.004233:0.003795:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.004536:0.006652:0.004233:0.004233
as in the GOlD 2019 guidelines  :@0.380873:0.946431:0.615275:0.946434:0.615275:0.929935:0.380873:0.929933:0.009979:0.006652:0.004233:0.003629:0.009071:0.004233:0.004536:0.009071:0.009676:0.004233:0.012700:0.012700:0.006652:0.010583:0.004233:0.008467:0.008467:0.008467:0.008467:0.004233:0.009979:0.009071:0.003629:0.009979:0.009676:0.003629:0.003629:0.009071:0.009676:0.006652:0.004895:-0.519290
1:@0.606130:0.941135:0.611041:0.941135:0.611041:0.931566:0.606130:0.931566:0.004911